NCT06408350Recruiting

Optimal Intervention to Full Viral Suppression: Text Me, Alexis!

Name: Clinical Trial NCT06408350
Creator: Friends Research Institute, Inc.
Keywords: HIV, Text Me, Alexis!, behavioral, clinical trial, United States of America

Comparative- and Cost-effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women Living With HIV to Full Viral Suppression

Friends Research Institute, Inc.ClinicalTrials.govbehavioral

Verified

Study focus

Disease/Condition: HIV
Drug/Device/Intervention: Text Me, Alexis!
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Friends Research Institute, Inc.
Location: Los Angeles, United States of America

Timeline & enrollment

Phase: N/A
Start date: Apr 11, 2024
End date: Jun 30, 2028
Enrollment: 195 participants

Primary outcome

Rate of HIV Viral Load Suppression,Relative Cost Effectiveness

Summary

Text Me, Alexis! is a three-arm randomized controlled trial (RCT) to determine the optimal and most cost-effective intervention for advancing trans women living with HIV to full viral suppression. Participants will be randomized (1:1:1) to Peer Health Navigation (PHN) alone, SMS (text messaging) alone, or PHN+SMS. Participants in the PHN alone and PHN+SMS arms will receive unlimited navigation sessions over 3 months. Participants in the SMS alone and PHN+SMS arms will receive 3 daily theory-based text messages for 90 days for a total of 270 unique scripted messages.

ICD-10 classifications

Human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other conditionsHIV disease resulting in other viral infectionsUnspecified human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other specified diseases

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06408350
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06408350 through Pure Global AI's free database. This phase not specified trial is sponsored by Friends Research Institute, Inc. and is currently Recruiting. The study focuses on HIV. Target enrollment is 195 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.